JNCE / Jounce Therapeutics Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Jounce Therapeutics Inc
US ˙ NASDAQ ˙ US4811161011
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier86.530.942 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Jounce Therapeutics Inc insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i JNCE / Jounce Therapeutics Inc. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2023-03-14 TANG KEVIN C 20.286 1,0180 20.286 1,0180 20.651 44 1.9350 18.602 90,08
2023-03-13 TANG KEVIN C 65.701 0,9940 65.701 0,9940 65.307
2018-06-15 Cole Hugh M 1.900 7,8400 1.900 7,8400 14.896
2017-02-01 Celgene Switzerland LLC 625.000 16,0000 625.000 16,0000 10.000.000
2017-02-01 KARSEN PERRY A 5.000 16,0000 5.000 16,0000 80.000
2017-02-01 Higgons John Duncan 6.700 16,0000 6.700 16,0000 107.200

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

JNCE / Jounce Therapeutics Inc Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i JNCE / Jounce Therapeutics Inc. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2023-01-10 Cole Hugh M 9.182 1,1200 9.182 1,1200 10.284 59 0.9001 -2.018 -19,63
2023-01-10 Trehu Elizabeth 5.126 1,1200 5.126 1,1200 5.741
2023-01-10 MURRAY RICHARD /CA/ 24.879 1,1200 24.879 1,1200 27.864
2023-01-10 Drapkin Kimberlee C 7.781 1,1200 7.781 1,1200 8.715
2023-01-09 Cole Hugh M 7.452 1,1000 7.452 1,1000 8.197
2023-01-09 Trehu Elizabeth 4.159 1,1000 4.159 1,1000 4.575
2023-01-09 MURRAY RICHARD /CA/ 20.191 1,1000 20.191 1,1000 22.210
2023-01-09 Drapkin Kimberlee C 6.315 1,1000 6.315 1,1000 6.946
2022-01-10 MURRAY RICHARD /CA/ 23.924 6,6500 23.924 6,6500 159.095

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

JNCE / Jounce Therapeutics Inc Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2023-05-05 2023-05-03 4 TANG KEVIN C By LP JNCE Common Stock J - Other I 9.737,7000 10.000 97.377 10.000
2023-05-05 2023-05-03 4 TANG KEVIN C By LP JNCE Common Stock U - Other I 1,8500 -5.300.087 -9.805 0
2023-05-05 2023-05-03 4 Concentra Biosciences, LLC JNCE Common Stock J - Other D 9.737,7000 10.000 97.377 10.000
2023-05-05 3 Concentra Merger Sub, Inc. By LP JNCE Common Stock I 36.367.727
2023-05-04 2023-05-03 4 Kamen Robert JNCE Common Stock U - Other I -33.875 0
2023-05-04 2023-05-03 4 Kamen Robert JNCE Common Stock U - Other D -60.975 0
2023-05-04 2023-05-03 4 MURRAY RICHARD /CA/ JNCE Common Stock U - Other D -188.778 1
2023-05-04 2023-05-03 4 KARSEN PERRY A JNCE Common Stock U - Other D -5.000 0
2023-05-04 2023-05-03 4 Drapkin Kimberlee C JNCE Common Stock U - Other D -40.267 0
2023-05-04 2023-05-03 4 Drapkin Kimberlee C JNCE Common Stock U - Other D -25.751 40.267
2023-04-06 2023-04-04 4 MURRAY RICHARD /CA/ JNCE Common Stock S - Sale D 1,8500 -39.228 -73 188.779
2023-03-14 2023-03-14 4 TANG KEVIN C By LP JNCE Common Stock P - Purchase I 1,0180 20.286 21 5.300.087
2023-03-14 2023-03-13 4 TANG KEVIN C By LP JNCE Common Stock P - Purchase I 0,9940 65.701 65 5.279.801
2023-03-14 3 TANG CAPITAL PARTNERS LP By LP JNCE Common Stock I 5.214.100
2023-01-11 2023-01-10 4 Trehu Elizabeth JNCE Common Stock S - Sale D 1,1200 -5.126 -6 103.417
2023-01-11 2023-01-09 4 Trehu Elizabeth JNCE Common Stock S - Sale D 1,1000 -4.159 -5 108.543
2023-01-11 2023-01-10 4 MURRAY RICHARD /CA/ JNCE Common Stock S - Sale D 1,1200 -24.879 -28 228.007
2023-01-11 2023-01-09 4 MURRAY RICHARD /CA/ JNCE Common Stock S - Sale D 1,1000 -20.191 -22 252.886
2023-01-11 2023-01-10 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 1,1200 -7.781 -9 66.018
2023-01-11 2023-01-09 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 1,1000 -6.315 -7 73.799
2023-01-11 2023-01-10 4 Cole Hugh M JNCE Common Stock S - Sale D 1,1200 -9.182 -10 110.082
2023-01-11 2023-01-09 4 Cole Hugh M JNCE Common Stock S - Sale D 1,1000 -7.452 -8 119.264
2022-08-03 2022-08-01 4 Cole Hugh M JNCE Common Stock A - Award D 20.000 126.716
2022-03-17 2022-02-01 4/A Cole Hugh M JNCE Stock Option (Right to Buy) A - Award D 7,56 85.000 85.000
2022-02-03 2022-02-01 4 MURRAY RICHARD /CA/ JNCE Stock Option (Right to Buy) A - Award D 7,56 175.000 175.000
2022-02-03 2022-02-01 4 MURRAY RICHARD /CA/ JNCE Common Stock A - Award D 87.500 273.077
2022-02-03 2022-02-01 4 Drapkin Kimberlee C JNCE Stock Option (Right to Buy) A - Award D 7,56 55.000 55.000
2022-02-03 2022-02-01 4 Drapkin Kimberlee C JNCE Common Stock A - Award D 27.500 80.114
2022-02-03 2022-02-01 4 Cole Hugh M JNCE Stock Option (Right to Buy) A - Award D 7,56 85.000 85.000
2022-02-03 2022-02-01 4 Cole Hugh M JNCE Common Stock A - Award D 42.500 106.716
2022-02-03 2022-02-01 4 Trehu Elizabeth JNCE Stock Option (Right to Buy) A - Award D 7,56 55.000 55.000
2022-02-03 2022-02-01 4 Trehu Elizabeth JNCE Common Stock A - Award D 27.500 112.702
2022-01-11 2022-01-10 4 Trehu Elizabeth JNCE Common Stock S - Sale D 6,6500 -5.378 -36 85.202
2022-01-11 2022-01-07 4 Trehu Elizabeth JNCE Common Stock S - Sale D 7,3000 -3.005 -22 90.580
2022-01-11 2022-01-10 4 MURRAY RICHARD /CA/ JNCE Common Stock S - Sale D 6,6500 -23.924 -159 185.577
2022-01-11 2022-01-07 4 MURRAY RICHARD /CA/ JNCE Common Stock S - Sale D 7,3000 -13.370 -98 209.501
2022-01-11 2022-01-10 4 Cole Hugh M JNCE Common Stock S - Sale D 6,6500 -6.205 -41 64.216
2022-01-11 2022-01-07 4 Cole Hugh M JNCE Common Stock S - Sale D 7,3000 -3.468 -25 70.421
2022-01-11 2022-01-10 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 6,6500 -8.222 -55 52.614
2022-01-11 2022-01-07 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 7,3000 -4.595 -34 60.836
2021-11-16 2021-11-12 4 Pfeffer Cary JNCE Common Stock S - Sale I 0 0
2021-11-16 2021-11-12 4 Third Rock Ventures III, L.P. JNCE Common Stock S - Sale D 8,3800 -1.900.000 -15.922 1.148.780
2021-09-17 2021-09-15 4 Third Rock Ventures II, L.P. JNCE Common Stock J - Other D -1.750.000 2.697.829
2021-09-17 2021-09-15 4 Pfeffer Cary JNCE Common Stock J - Other I 0 0
2021-09-15 2021-09-13 4 Raythatha Jigar JNCE Common Stock A - Award D 6,47 31.400 31.400
2021-06-22 2021-06-18 4 Pfeffer Cary JNCE Stock Option (Right to Buy) A - Award D 7,27 15.700 15.700
2021-06-22 2021-06-18 4 Salter-Cid Luisa JNCE Stock Option (Right to Buy) A - Award D 7,27 7.850 7.850
2021-06-22 2021-06-18 4 Kamen Robert JNCE Stock Option (Right to Buy) A - Award D 7,27 15.700 15.700
2021-06-22 2021-06-18 4 Iannone Robert JNCE Stock Option (Right to Buy) A - Award D 7,27 15.700 15.700
2021-06-22 2021-06-18 4 Higgons John Duncan JNCE Stock Option (Right to Buy) A - Award D 7,27 15.700 15.700
2021-06-22 2021-06-18 4 Duncan Barbara Gayle JNCE Stock Option (Right to Buy) A - Award D 7,27 15.700 15.700
2021-06-22 2021-06-18 4 Diaz Luis JNCE Stock Option (Right to Buy) A - Award D 7,27 15.700 15.700
2021-06-22 2021-06-18 4 KARSEN PERRY A JNCE Stock Option (Right to Buy) A - Award D 7,27 15.700 15.700
2021-06-14 2021-06-10 4 Pfeffer Cary JNCE Common Stock J - Other I 0 0
2021-06-14 2021-06-10 4 Third Rock Ventures II, L.P. JNCE Common Stock J - Other D -1.500.000 4.447.829
2021-05-27 2021-05-25 4 Third Rock Ventures II, L.P. JNCE Common Stock S - Sale D 8,0000 -552.520 -4.420 5.947.829
2021-04-16 2021-04-15 4 Higgons John Duncan JNCE Common Stock S - Sale D 10,0000 -200 -2 9.713
2021-03-31 2021-03-31 4 Trehu Elizabeth JNCE Stock Option (Right to Buy) M - Exercise D 4,02 -8.300 203.885
2021-03-31 2021-03-31 4 Trehu Elizabeth JNCE Common Stock S - Sale D 10,0900 -8.300 -84 93.585
2021-03-31 2021-03-31 4 Trehu Elizabeth JNCE Common Stock M - Exercise D 4,0200 8.300 33 101.885
2021-03-31 2021-03-30 4 Trehu Elizabeth JNCE Stock Option (Right to Buy) M - Exercise D 4,02 -100 212.185
2021-03-31 2021-03-30 4 Trehu Elizabeth JNCE Common Stock S - Sale D 10,0000 -100 -1 93.585
2021-03-31 2021-03-30 4 Trehu Elizabeth JNCE Common Stock M - Exercise D 4,0200 100 0 93.685
2021-03-31 2021-03-29 4 Trehu Elizabeth JNCE Stock Option (Right to Buy) M - Exercise D 4,02 -5.100 212.285
2021-03-31 2021-03-29 4 Trehu Elizabeth JNCE Common Stock S - Sale D 10,0900 -5.100 -51 93.585
2021-03-31 2021-03-29 4 Trehu Elizabeth JNCE Common Stock M - Exercise D 4,0200 5.100 21 98.685
2021-03-17 2021-03-15 4 Higgons John Duncan JNCE Common Stock S - Sale D 12,8000 -200 -3 9.913
2021-03-15 2021-03-11 4 Pfeffer Cary JNCE Common Stock J - Other I 0 0
2021-03-15 2021-03-11 4 Third Rock Ventures II, L.P. JNCE Common Stock J - Other D -1.250.000 6.500.349
2021-03-03 2021-03-01 4 Pfeffer Cary JNCE Common Stock S - Sale I 0 0
2021-03-03 2021-03-01 4 Third Rock Ventures II, L.P. JNCE Common Stock S - Sale D 11,7500 -1.450.000 -17.038 7.750.349
2021-02-18 2021-02-16 4 Higgons John Duncan JNCE Common Stock S - Sale D 11,7800 -200 -2 10.113
2021-02-12 2021-02-10 4 Salter-Cid Luisa JNCE Stock Option (Right to Buy) A - Award D 12,36 31.400 31.400
2021-02-03 2021-02-01 4 Trehu Elizabeth JNCE Stock Option (Right to Buy) A - Award D 11,89 44.500 44.500
2021-02-03 2021-02-01 4 Trehu Elizabeth JNCE Common Stock A - Award D 22.250 93.585
2021-02-03 2021-02-03 4 MURRAY RICHARD /CA/ JNCE Common Stock A - Award D 7.500 222.871
2021-02-03 2021-02-01 4 MURRAY RICHARD /CA/ JNCE Stock Option (Right to Buy) A - Award D 12,67 15.000 15.000
2021-02-03 2021-02-01 4 MURRAY RICHARD /CA/ JNCE Stock Option (Right to Buy) A - Award D 11,89 150.000 150.000
2021-02-03 2021-02-01 4 MURRAY RICHARD /CA/ JNCE Common Stock A - Award D 75.000 215.371
2021-02-03 2021-02-01 4 Drapkin Kimberlee C JNCE Stock Option (Right to Buy) A - Award D 11,89 44.500 44.500
2021-02-03 2021-02-01 4 Drapkin Kimberlee C JNCE Common Stock A - Award D 22.250 65.431
2021-02-03 2021-02-01 4 Cole Hugh M JNCE Stock Option (Right to Buy) A - Award D 11,89 11,8900 53.400 635 53.400
2021-02-03 2021-02-01 4 Cole Hugh M JNCE Common Stock A - Award D 26.700 73.889
2021-01-25 2021-01-21 4 MURRAY RICHARD /CA/ JNCE Stock Option (Right to Buy) M - Exercise D 0,48 -33.518 665.169
2021-01-25 2021-01-21 4 MURRAY RICHARD /CA/ JNCE Common Stock S - Sale D 12,0600 -33.518 -404 140.371
2021-01-25 2021-01-21 4 MURRAY RICHARD /CA/ JNCE Common Stock M - Exercise D 0,4800 33.518 16 173.889
2021-01-25 2021-01-22 4 Cole Hugh M JNCE Stock Option (Right to Buy) M - Exercise D 6,55 -5.000 55.000
2021-01-25 2021-01-22 4 Cole Hugh M JNCE Stock Option (Right to Buy) M - Exercise D 4,40 -5.000 55.000
2021-01-25 2021-01-22 4 Cole Hugh M JNCE Common Stock S - Sale D 11,9500 -18.000 -215 47.189
2021-01-25 2021-01-22 4 Cole Hugh M JNCE Common Stock M - Exercise D 6,5500 5.000 33 65.189
2021-01-25 2021-01-22 4 Cole Hugh M JNCE Common Stock M - Exercise D 4,4000 5.000 22 60.189
2021-01-22 2021-01-20 4 Trehu Elizabeth JNCE Stock Option (Right to Buy) M - Exercise D 4,02 -6.500 7.050
2021-01-22 2021-01-20 4 Trehu Elizabeth JNCE Common Stock S - Sale D 12,0100 -6.500 -78 71.335
2021-01-22 2021-01-20 4 Trehu Elizabeth JNCE Common Stock M - Exercise D 4,0200 6.500 26 77.835
2021-01-22 2021-01-21 4 Higgons John Duncan JNCE Common Stock S - Sale D 11,1100 -200 -2 10.313
2021-01-22 2021-01-20 4 Higgons John Duncan JNCE Common Stock S - Sale D 12,0000 -1.500 -18 10.513
2021-01-22 2021-01-21 4 Drapkin Kimberlee C JNCE Stock Option (Right to Buy) M - Exercise D 2,36 -3.799 206.005
2021-01-22 2021-01-21 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 12,0000 -3.799 -46 43.181
2021-01-22 2021-01-21 4 Drapkin Kimberlee C JNCE Common Stock M - Exercise D 2,3600 3.799 9 46.980
2021-01-22 2021-01-20 4 Drapkin Kimberlee C JNCE Stock Option (Right to Buy) M - Exercise D 2,36 -3.710 209.804
2021-01-22 2021-01-20 4 Drapkin Kimberlee C JNCE Stock Option (Right to Buy) M - Exercise D 0,74 -6.775 0
2021-01-22 2021-01-20 4 Drapkin Kimberlee C JNCE Stock Option (Right to Buy) M - Exercise D 0,48 -3.016 0
2021-01-22 2021-01-20 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 10,0300 -10.000 -100 43.181
2021-01-22 2021-01-20 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 12,0300 -16.201 -195 53.181
2021-01-22 2021-01-20 4 Drapkin Kimberlee C JNCE Common Stock M - Exercise D 2,3600 3.710 9 69.382
2021-01-22 2021-01-20 4 Drapkin Kimberlee C JNCE Common Stock M - Exercise D 0,7400 6.775 5 65.672
2021-01-22 2021-01-20 4 Drapkin Kimberlee C JNCE Common Stock M - Exercise D 0,4800 3.016 1 58.897
2021-01-20 2021-01-20 4 MURRAY RICHARD /CA/ JNCE Stock Option (Right to Buy) M - Exercise D 0,48 -16.482 698.687
2021-01-20 2021-01-20 4 MURRAY RICHARD /CA/ JNCE Common Stock S - Sale D 12,0400 -16.482 -198 140.371
2021-01-20 2021-01-20 4 MURRAY RICHARD /CA/ JNCE Common Stock M - Exercise D 0,4800 16.482 8 156.853
2021-01-20 2021-01-19 4 MURRAY RICHARD /CA/ JNCE Stock Option (Right to Buy) M - Exercise D 0,48 -40.000 715.169
2021-01-20 2021-01-19 4 MURRAY RICHARD /CA/ JNCE Common Stock S - Sale D 9,5900 -40.000 -384 140.371
2021-01-20 2021-01-19 4 MURRAY RICHARD /CA/ JNCE Common Stock M - Exercise D 0,4800 40.000 19 180.371
2021-01-20 2021-01-15 4 MURRAY RICHARD /CA/ JNCE Stock Option (Right to Buy) M - Exercise D 0,48 -30.000 755.169
2021-01-20 2021-01-15 4 MURRAY RICHARD /CA/ JNCE Common Stock S - Sale D 8,5400 -30.000 -256 140.371
2021-01-20 2021-01-15 4 MURRAY RICHARD /CA/ JNCE Common Stock M - Exercise D 0,4800 30.000 14 170.371
2021-01-11 2021-01-08 4 Trehu Elizabeth JNCE Common Stock S - Sale D 7,0000 -2.846 -20 71.335
2021-01-11 2021-01-07 4 Trehu Elizabeth JNCE Common Stock S - Sale D 6,7600 -2.452 -17 74.181
2021-01-11 2021-01-08 4 MURRAY RICHARD /CA/ JNCE Common Stock S - Sale D 7,0000 -11.816 -83 140.371
2021-01-11 2021-01-07 4 MURRAY RICHARD /CA/ JNCE Common Stock S - Sale D 6,7600 -10.183 -69 152.187
2021-01-11 2021-01-08 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 7,0000 -3.130 -22 55.881
2021-01-11 2021-01-07 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 6,7600 -2.697 -18 59.011
2021-01-11 2021-01-08 4 Cole Hugh M JNCE Common Stock S - Sale D 7,0000 -3.340 -23 55.189
2021-01-11 2021-01-07 4 Cole Hugh M JNCE Common Stock S - Sale D 6,7600 -2.879 -19 58.529
2020-11-23 2020-11-19 4 Pfeffer Cary JNCE Common Stock S - Sale I 0 0
2020-11-23 2020-11-19 4 Third Rock Ventures II, L.P. JNCE Common Stock S - Sale D 7,0050 -15.000 -105 9.200.349
2020-11-19 2020-11-17 4 Third Rock Ventures II, L.P. JNCE Common Stock S - Sale D 7,2515 -15.000 -109 9.215.349
2020-11-19 2020-11-17 4 Pfeffer Cary JNCE Common Stock S - Sale I 0 0
2020-11-13 2020-11-11 4 Third Rock Ventures II, L.P. JNCE Common Stock J - Other D -1.000.000 9.230.349
2020-11-13 2020-11-11 4 Pfeffer Cary JNCE Common Stock J - Other I 0 0
2020-10-26 3 GILEAD SCIENCES INC JNCE Common Stock D 5.539.727
2020-09-16 2020-09-15 4 Duncan Barbara Gayle JNCE Stock Option (Right to Buy) M - Exercise D 4,21 -10.000 34.271
2020-09-16 2020-09-15 4 Duncan Barbara Gayle JNCE Common Stock S - Sale D 10,5000 -5.000 -52 0
2020-09-16 2020-09-15 4 Duncan Barbara Gayle JNCE Common Stock S - Sale D 9,5000 -5.000 -48 5.000
2020-09-16 2020-09-15 4 Duncan Barbara Gayle JNCE Common Stock M - Exercise D 4,2100 10.000 42 10.000
2020-09-02 2020-09-01 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 8,0600 -7.200 -58 61.708
2020-08-18 2020-08-18 4 Cole Hugh M JNCE Common Stock S - Sale D 4,7100 -744 -4 61.408
2020-08-18 2020-08-17 4 Cole Hugh M JNCE Common Stock S - Sale D 4,8600 -454 -2 62.152
2020-08-18 2020-08-14 4 Cole Hugh M JNCE Common Stock S - Sale D 4,6400 -984 -5 62.606
2020-08-18 2020-08-17 4 Trehu Elizabeth JNCE Common Stock S - Sale D 4,8600 -454 -2 77.377
2020-08-18 2020-08-14 4 Trehu Elizabeth JNCE Common Stock S - Sale D 4,7100 -744 -4 76.633
2020-08-18 2020-08-14 4 Trehu Elizabeth JNCE Common Stock S - Sale D 4,6400 -984 -5 77.831
2020-08-18 2020-08-18 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 4,7100 -744 -4 68.908
2020-08-18 2020-08-17 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 4,8600 -454 -2 69.652
2020-08-18 2020-08-14 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 4,6400 -984 -5 70.106
2020-07-02 2020-06-26 4/A Duncan Barbara Gayle JNCE Stock Option (Right to Buy) A - Award D 7,58 15.700 15.700
2020-07-02 2020-06-26 4/A Diaz Luis JNCE Stock Option (Right to Buy) A - Award D 7,58 15.700 15.700
2020-07-02 2020-06-26 4/A Higgons John Duncan JNCE Stock Option (Right to Buy) A - Award D 7,58 15.700 15.700
2020-07-02 2020-06-26 4/A Iannone Robert JNCE Stock Option (Right to Buy) A - Award D 7,58 7.850 7.850
2020-07-02 2020-06-26 4/A Kamen Robert JNCE Stock Option (Right to Buy) A - Award D 7,58 15.700 15.700
2020-07-02 2020-06-26 4/A KARSEN PERRY A JNCE Stock Option (Right to Buy) A - Award D 7,58 15.700 15.700
2020-07-02 2020-06-26 4/A Pfeffer Cary JNCE Stock Option (Right to Buy) A - Award D 7,58 15.700 15.700
2020-07-02 2020-06-26 4/A TEPPER ROBERT I JNCE Stock Option (Right to Buy) A - Award D 7,58 15.700 15.700
2020-06-29 2020-06-26 4 Iannone Robert JNCE Stock Option (Right to Buy) A - Award D 7,58 6.775 6.775
2020-06-29 2020-06-26 4 Pfeffer Cary JNCE Stock Option (Right to Buy) A - Award D 7,58 13.550 13.550
2020-06-29 2020-06-26 4 Diaz Luis JNCE Stock Option (Right to Buy) A - Award D 7,58 13.550 13.550
2020-02-04 2020-02-03 4 Drapkin Kimberlee C JNCE Common Stock A - Award D 6,55 53.400 53.400
2020-02-04 2020-02-03 4 Drapkin Kimberlee C JNCE Common Stock A - Award D 26.700 71.090
2020-02-04 2020-02-03 4 MURRAY RICHARD /CA/ JNCE Stock Option (Right to Buy) A - Award D 6,55 150.010 150.010
2020-02-04 2020-02-03 4 MURRAY RICHARD /CA/ JNCE Common Stock A - Award D 75.010 162.370
2020-02-04 2020-02-03 4 Cole Hugh M JNCE Common Stock A - Award D 6,55 60.000 60.000
2020-02-04 2020-02-03 4 Cole Hugh M JNCE Common Stock A - Award D 30.000 63.590
2020-02-04 2020-02-03 4 Trehu Elizabeth JNCE Common Stock A - Award D 6,55 44.500 44.500
2020-02-04 2020-02-03 4 Trehu Elizabeth JNCE Common Stock A - Award D 22.250 78.815
2020-01-23 2020-01-21 4 Iannone Robert JNCE Stock Option (Right to Buy) A - Award D 7,19 31.400 31.400
2020-01-10 2020-01-07 4 Cole Hugh M JNCE Common Stock S - Sale D 7,7800 -2.624 -20 33.590
2020-01-10 2020-01-07 4 MURRAY RICHARD /CA/ JNCE Common Stock S - Sale D 7,7800 -7.150 -56 87.360
2020-01-10 2020-01-07 4 Trehu Elizabeth JNCE Common Stock S - Sale D 7,7800 -2.624 -20 56.565
2020-01-10 2020-01-07 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 7,7800 -2.624 -20 44.390
2020-01-08 2020-01-06 4 Higgons John Duncan JNCE Common Stock S - Sale D 8,1100 -1.500 -12 12.013
2019-12-26 2019-12-23 4 MURRAY RICHARD /CA/ JNCE Stock Option (Right to Buy) M - Exercise D 0,48 0,4800 -40.000 -19 785.169
2019-12-26 2019-12-23 4 MURRAY RICHARD /CA/ JNCE Common Stock S - Sale D 8,3700 -40.000 -335 94.510
2019-12-26 2019-12-23 4 MURRAY RICHARD /CA/ JNCE Common Stock M - Exercise D 0,4800 40.000 19 134.510
2019-08-16 2019-08-16 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 3,9200 -1.018 -4 47.014
2019-08-16 2019-08-15 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 4,0000 -648 -3 48.032
2019-08-16 2019-08-14 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 4,1000 -670 -3 48.680
2019-08-16 2019-08-16 4 Trehu Elizabeth JNCE Common Stock S - Sale D 3,9200 -1.018 -4 59.189
2019-08-16 2019-08-15 4 Trehu Elizabeth JNCE Common Stock S - Sale D 4,0000 -648 -3 60.207
2019-08-16 2019-08-14 4 Trehu Elizabeth JNCE Common Stock S - Sale D 4,1000 -670 -3 60.855
2019-08-16 2019-08-16 4 Cole Hugh M JNCE Common Stock S - Sale D 3,9200 -1.018 -4 36.214
2019-08-16 2019-08-15 4 Cole Hugh M JNCE Common Stock S - Sale D 4,0000 -648 -3 37.232
2019-08-16 2019-08-14 4 Cole Hugh M JNCE Common Stock S - Sale D 4,1000 -670 -3 37.880
2019-06-13 2019-06-12 4 Higgons John Duncan JNCE Stock Option (Right to Buy) A - Award D 4,46 15.700 15.700
2019-06-13 2019-06-12 4 KARSEN PERRY A JNCE Stock Option (Right to Buy) A - Award D 4,46 15.700 15.700
2019-06-13 2019-06-12 4 Pfeffer Cary JNCE Stock Option (Right to Buy) A - Award D 4,46 15.700 15.700
2019-06-13 2019-06-12 4 Kamen Robert JNCE Stock Option (Right to Buy) A - Award D 4,46 15.700 15.700
2019-06-13 2019-06-12 4 Duncan Barbara Gayle JNCE Stock Option (Right to Buy) A - Award D 4,46 15.700 15.700
2019-06-13 2019-06-12 4 Diaz Luis JNCE Stock Option (Right to Buy) A - Award D 4,46 15.700 15.700
2019-06-13 2019-06-12 4 TEPPER ROBERT I JNCE Stock Option (Right to Buy) A - Award D 4,46 15.700 15.700
2019-02-05 2019-02-01 4 MURRAY RICHARD /CA/ JNCE Stock Option (Right to Buy) A - Award D 4,40 125.010 125.010
2019-02-05 2019-02-01 4 MURRAY RICHARD /CA/ JNCE Common Stock A - Award D 62.510 94.510
2019-02-05 2019-02-01 4 Drapkin Kimberlee C JNCE Stock Option (Right to Buy) A - Award D 4,40 44.500 44.500
2019-02-05 2019-02-01 4 Drapkin Kimberlee C JNCE Common Stock A - Award D 22.250 49.350
2019-02-05 2019-02-01 4 Cole Hugh M JNCE Stock Option (Right to Buy) A - Award D 4,40 44.500 44.500
2019-02-05 2019-02-01 4 Cole Hugh M JNCE Common Stock A - Award D 22.250 38.550
2019-02-05 2019-02-01 4 Trehu Elizabeth JNCE Stock Option (Right to Buy) A - Award D 4,40 44.500 44.500
2019-02-05 2019-02-01 4 Trehu Elizabeth JNCE Common Stock A - Award D 22.250 61.525
2018-09-07 2018-09-06 4 MURRAY RICHARD /CA/ JNCE Stock Option (Right to Buy) M - Exercise D 0,48 -32.000 825.169
2018-09-07 2018-09-06 4 MURRAY RICHARD /CA/ JNCE Common Stock M - Exercise D 0,4800 32.000 15 32.000
2018-08-28 2018-08-27 4 Drapkin Kimberlee C JNCE Stock Option (Right to Buy) M - Exercise D 2,36 -12.700 213.514
2018-08-28 2018-08-27 4 Drapkin Kimberlee C JNCE Common Stock M - Exercise D 2,3600 12.700 30 27.100
2018-08-15 2018-08-13 4 Drapkin Kimberlee C JNCE Common Stock A - Award D 14.400 14.400
2018-08-15 2018-08-13 4 Cole Hugh M JNCE Common Stock A - Award D 14.400 16.300
2018-08-15 2018-08-13 4 Trehu Elizabeth JNCE Common Stock A - Award D 14.400 39.275
2018-06-21 2018-06-19 4 KARSEN PERRY A JNCE Stock Option (Right to Buy) A - Award D 7,92 13.550 13.550
2018-06-21 2018-06-19 4 Kamen Robert JNCE Stock Option (Right to Buy) A - Award D 7,92 13.550 13.550
2018-06-21 2018-06-19 4 Pfeffer Cary JNCE Stock Option (Right to Buy) A - Award D 7,92 13.550 13.550
2018-06-21 2018-06-19 4 TEPPER ROBERT I JNCE Stock Option (Right to Buy) A - Award D 7,92 13.550 13.550
2018-06-21 2018-06-19 4 Diaz Luis JNCE Stock Option (Right to Buy) A - Award D 7,92 10.163 10.163
2018-06-21 2018-06-19 4 Duncan Barbara Gayle JNCE Stock Option (Right to Buy) A - Award D 7,92 13.550 13.550
2018-06-21 2018-06-19 4 Higgons John Duncan JNCE Stock Option (Right to Buy) A - Award D 7,92 13.550 13.550
2018-06-18 2018-06-15 4 Cole Hugh M JNCE Common Stock P - Purchase D 7,8400 1.900 15 1.900
2018-06-12 2018-06-08 4 Trehu Elizabeth JNCE Stock Option (Right to Buy) M - Exercise D 4,02 4,0200 -24.875 -100 217.385
2018-06-12 2018-06-08 4 Trehu Elizabeth JNCE Common Stock M - Exercise D 4,0200 24.875 100 24.875
2018-03-19 2018-03-15 4 Duncan Barbara Gayle JNCE Stock Option (Right to Buy) M - Exercise D 4,21 -2.000 44.271
2018-03-19 2018-03-15 4 Duncan Barbara Gayle JNCE Common Stock S - Sale D 28,1100 -2.000 -56 0
2018-03-19 2018-03-15 4 Duncan Barbara Gayle JNCE Common Stock M - Exercise D 4,2100 2.000 8 2.000
2018-03-12 2018-03-08 4 Drapkin Kimberlee C JNCE Stock Option (Right to Buy) M - Exercise D 0,48 -3.759 3.016
2018-03-12 2018-03-08 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 25,0100 -5.267 -132 0
2018-03-12 2018-03-08 4 Drapkin Kimberlee C JNCE Common Stock M - Exercise D 0,4800 3.759 2 5.267
2018-03-12 2018-03-08 4 MURRAY RICHARD /CA/ JNCE Stock Option (Right to Buy) M - Exercise D 0,48 -16.334 857.169
2018-03-12 2018-03-08 4 MURRAY RICHARD /CA/ JNCE Common Stock S - Sale D 25,1000 -16.334 -410 0
2018-03-12 2018-03-08 4 MURRAY RICHARD /CA/ JNCE Common Stock M - Exercise D 0,4800 16.334 8 16.334
2018-03-12 2018-03-08 4 Trehu Elizabeth JNCE Stock Option (Right to Buy) M - Exercise D 4,02 -4.545 242.260
2018-03-12 2018-03-08 4 Trehu Elizabeth JNCE Common Stock S - Sale D 25,0600 -4.545 -114 0
2018-03-12 2018-03-08 4 Trehu Elizabeth JNCE Common Stock M - Exercise D 4,0200 4.545 18 4.545
2018-03-07 2018-03-05 4 MURRAY RICHARD /CA/ JNCE Stock Option (Right to Buy) M - Exercise D 0,48 -16.334 873.503
2018-03-07 2018-03-05 4 MURRAY RICHARD /CA/ JNCE Common Stock S - Sale D 22,0600 -4.234 -93 0
2018-03-07 2018-03-05 4 MURRAY RICHARD /CA/ JNCE Common Stock S - Sale D 21,2100 -12.100 -257 4.234
2018-03-07 2018-03-05 4 MURRAY RICHARD /CA/ JNCE Common Stock M - Exercise D 0,4800 16.334 8 16.334
2018-03-07 2018-03-05 4 Trehu Elizabeth JNCE Stock Option (Right to Buy) M - Exercise D 4,02 -4.545 246.805
2018-03-07 2018-03-05 4 Trehu Elizabeth JNCE Common Stock S - Sale D 22,1100 -1.366 -30 0
2018-03-07 2018-03-05 4 Trehu Elizabeth JNCE Common Stock S - Sale D 21,2400 -3.179 -68 1.366
2018-03-07 2018-03-05 4 Trehu Elizabeth JNCE Common Stock M - Exercise D 4,0200 4.545 18 4.545
2018-03-07 2018-03-05 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 22,0700 -1.267 -28 1.508
2018-03-07 2018-03-05 4 Drapkin Kimberlee C JNCE Common Stock S - Sale D 21,2100 -4.000 -85 2.775
2018-02-05 2018-02-01 4 Cole Hugh M JNCE Stock Option (Right to Buy) A - Award D 23,98 70.500 70.500
2018-02-05 2018-02-01 4 Drapkin Kimberlee C JNCE Stock Option (Right to Buy) A - Award D 23,98 97.500 97.500
2018-02-05 2018-02-01 4 MURRAY RICHARD /CA/ JNCE Stock Option (Right to Buy) A - Award D 23,98 200.000 200.000
2018-02-05 2018-02-01 4 Trehu Elizabeth JNCE Stock Option (Right to Buy) A - Award D 23,98 70.500 70.500
2018-01-29 2018-01-26 4 Duncan Barbara Gayle JNCE Stock Option (Right to Buy) M - Exercise D 4,21 4,2100 -4.000 -17 46.271
2018-01-29 2018-01-26 4 Duncan Barbara Gayle JNCE Common Stock S - Sale D 25,0000 -4.000 -100 0
2018-01-29 2018-01-26 4 Duncan Barbara Gayle JNCE Common Stock M - Exercise D 4,2100 4.000 17 4.000
2017-10-23 2017-10-20 4 Diaz Luis JNCE Stock Option (Right to Buy) A - Award D 14,78 27.100 27.100
2017-02-03 2017-02-01 4 Pfeffer Cary JNCE Series A Preferred Stock C - Conversion I 0 0
2017-02-03 2017-02-01 4 Pfeffer Cary JNCE Series A Preferred Stock C - Conversion I 0 0
2017-02-03 2017-02-01 4 Pfeffer Cary JNCE Common Stock C - Conversion I 0 0
2017-02-03 2017-02-01 4 Pfeffer Cary JNCE Common Stock C - Conversion I 0 0
2017-02-03 2017-02-01 4 TEPPER ROBERT I JNCE Series A Preferred Stock C - Conversion I -11.250.000 0
2017-02-03 2017-02-01 4 TEPPER ROBERT I JNCE Series A Preferred Stock C - Conversion I -35.750.000 0
2017-02-03 2017-02-01 4 TEPPER ROBERT I JNCE Common Stock C - Conversion I 3.048.780 3.048.780
2017-02-03 2017-02-01 4 TEPPER ROBERT I JNCE Common Stock C - Conversion I 9.688.344 10.230.349
2017-02-03 2017-02-01 4 Third Rock Ventures II, L.P. JNCE Series A Preferred Stock C - Conversion D -11.250.000 0
2017-02-03 2017-02-01 4 Third Rock Ventures II, L.P. JNCE Series A Preferred Stock C - Conversion D -35.750.000 0
2017-02-03 2017-02-01 4 Third Rock Ventures II, L.P. JNCE Common Stock C - Conversion D 3.048.780 3.048.780
2017-02-03 2017-02-01 4 Third Rock Ventures II, L.P. JNCE Common Stock C - Conversion D 9.688.344 10.230.349
2017-02-02 2017-02-01 4 Higgons John Duncan JNCE Common Stock P - Purchase D 16,0000 6.700 107 27.025
2017-02-02 2017-02-01 4 KARSEN PERRY A JNCE Common Stock P - Purchase D 16,0000 5.000 80 5.000
2017-02-01 2017-02-01 4 Hadley Harbor Master Investors (Cayman) L.P. JNCE Series B Convertible Preferred Stock C - Conversion D -2.654.867 0
2017-02-01 2017-02-01 4 Hadley Harbor Master Investors (Cayman) L.P. JNCE Common Stock C - Conversion D 719.476 719.476
2017-02-01 2017-02-01 4 Celgene Switzerland LLC JNCE Series B-1 Preferred Stock C - Conversion D -10.448.100 0
2017-02-01 2017-02-01 4 Celgene Switzerland LLC JNCE Common Stock P - Purchase D 16,0000 625.000 10.000 3.456.463
2017-02-01 2017-02-01 4 Celgene Switzerland LLC JNCE Common Stock C - Conversion D 2.831.463 2.831.463
2017-01-26 3 Pfeffer Cary JNCE Common Stock I 0
2017-01-26 3 Kamen Robert JNCE Common Stock I 128.725
2017-01-26 3 Kamen Robert JNCE Common Stock I 128.725
2017-01-26 3 Kamen Robert JNCE Common Stock D 155.825
2017-01-26 3 Kamen Robert JNCE Common Stock D 155.825
2017-01-26 3 Higgons John Duncan JNCE Common Stock D 40.650
2017-01-26 3 Higgons John Duncan JNCE Common Stock D 40.650
2017-01-26 3 Hadley Harbor Master Investors (Cayman) L.P. JNCE No securities are benefically owned D 0
2017-01-26 3 Drapkin Kimberlee C JNCE Common Stock D 13.550
2017-01-26 3 Drapkin Kimberlee C JNCE Common Stock D 13.550
2017-01-26 3 TEPPER ROBERT I JNCE Common Stock I 1.084.010
2017-01-26 3 TEPPER ROBERT I JNCE Common Stock I 1.084.010
2017-01-26 3 STARR KEVIN P JNCE Common Stock D 1.084.010
2017-01-26 3 STARR KEVIN P JNCE Common Stock D 1.084.010
2017-01-26 3 STARR KEVIN P JNCE Common Stock D 1.084.010
2017-01-26 3 STARR KEVIN P JNCE Common Stock D 1.084.010
2017-01-26 3 STARR KEVIN P JNCE Common Stock D 1.084.010
2017-01-26 3 STARR KEVIN P JNCE Common Stock D 1.084.010
2017-01-26 3 STARR KEVIN P JNCE Common Stock D 1.084.010
2017-01-26 3 STARR KEVIN P JNCE Common Stock D 1.084.010
2017-01-26 3 STARR KEVIN P JNCE Common Stock D 1.084.010
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista